⏳ Fetching live dividend data...
Home › Calculator › MCTA Dividend Calculator 2026
Charming Medical Limited Class A Ordinary Shares · NASDAQ
Price: $29.36 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MCTA → $3.15M in 10 years · $61.99/month
Operating through its subsidiaries and under the Beauty Lab brand in Hong Kong, Charming Medical Limited delivers a comprehensive suite of beauty, wellness, and postpartum services. These services encompass womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox, agarwood moxibustion, TCM-inspired prenatal massages, and Indonesian traditional abdominal binding. In addition to these treatments, the company manufactures and distributes various products. Their product line features TCM-inspired supplements, including the Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets. They also offer beauty products like a ginseng soothing anti-allergy moisturizing wash for various skin issues and solutions for scalp health. The company further provides consultancy services, offering technical training in TCM-inspired therapies and dietary guidance to other well-regarded beauty salons, massage centers, and similar institutions. These services and products are specifically formulated to alleviate premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal symptoms, and concerns related to breast and uterine health. They also contribute to enhancing overall physical strength and balancing endocrine functions, addressing a wide array of common women's health challenges. Charming Medical operates its own network of wellness centers. Founded in 2016, the company maintains its headquarters in Causeway Bay, Hong Kong.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MCTA position with:
Real after-tax yield depends on where you live and how you hold MCTA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 6.81% | 4.01% | $681 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 5.79% | 2.99% | $579 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 5.45% | 2.65% | $545 / yr |
| 🇬🇧 UK ISA | 0% | 6.81% | 4.01% | $681 / yr |
| 🇬🇧 UK Taxable | 8.75% | 6.21% | 3.41% | $621 / yr |
| 🇨🇦 TFSA | 0% | 6.81% | 4.01% | $681 / yr |
| 🇨🇦 CA Taxable | 25% | 5.11% | 2.31% | $511 / yr |
| 🇦🇺 Super (pension) | 15% | 5.79% | 2.99% | $579 / yr |
| 🇦🇺 AU Taxable | 30% | 4.77% | 1.97% | $477 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5.01% | 2.21% | $501 / yr |
| 🇫🇷 FR Taxable | 30% | 4.77% | 1.97% | $477 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MCTA pays quarterly — 4 times per year. Next ex-div: TBD.
How MCTA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MCTA sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MCTA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Charming Medical Limited Class A Ordinary Shares (MCTA) is currently trading at $29.36, trading near its 52-week high. The current dividend yield is 6.81% based on an annual payout of $2.00 per share.
Charming Medical Limited Class A Ordinary Shares (MCTA) is a healthcare stock currently trading at $29.36 with a dividend yield of 6.81%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →